Ralox works to prevent osteoporosis by strengthening bones, increasing their density, reducing the possibility of fractures, preventing osteoporosis in postmenopausal women, and preventing breast cancer. Some studies have indicated that
Ralox can be used to reduce the risk of breast cancer, as it works as an estrogen receptor antagonist, which reduces the effect of estrogen on breast cells and prevents breast cancer, especially in postmenopausal women, especially those who suffer from osteoporosis or have a greater chance of developing breast cancer.